While a Korean case–control study suggested a modest association between MLH1 polymorphisms and BC risk, subsequent studies in other populations, including Chinese and Iranian cohorts, did not confirm significant effects [15,16,17,18]. This evidence concerns the gene MLH1 and breast cancer.